University research records

Novosibirsk State Medical University

2 imported, source-linked research records. Published in the last five years.

Published in the last five years

2 matching research records

Topic: Canagliflozin and SGLT2. Only records linked to Novosibirsk State Medical University are included. Historical ingestion is still running; these are imported records, not a count of all research worldwide.

Back to university profile →

Showing 1–2 of 2 matching records. Counts update as records arrive.

  1. The role of canagliflozin in the prevention of stroke and chronic kidney disease in patients with type 2 diabetes mellitus: an expert council resolution

    October 23, 2023 · 0 citations · Open access

    Open original record →

  2. Potential new application points of SGLT2 inhibitors in patients with heart failure in combination with diabetes mellitus, non-alcoholic fatty liver disease and anemia (literature review)

    December 25, 2022 · 3 citations · Open access

    Open original record →